Anticorps Recombinant de lapin anti-VEGFR2/CD309
VEGFR2/CD309 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC
Conjugaison
Non conjugué
CloneNo.
240214D7
N° de cat : 98027-2-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
98027-2-PBS cible VEGFR2/CD309 dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | kinase insert domain protein receptor |
| Masse moléculaire calculée | 150KD |
| Numéro d’acquisition GenBank | NM_010612.2 |
| Symbole du gène | VEGFR-2 |
| Identification du gène (NCBI) | 16542 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. |
Informations générales
VEGFR2, also named as CD309, KDR and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.



